Loading organizations...
Loading organizations...
Peptide synthesis and purification solutions with cloud platform access.
Mytide Therapeutics has raised $7.0M across 1 funding round.
Mytide Therapeutics has raised $7.0M in total across 1 funding round.
Mytide Therapeutics has raised $7.0M in total across 1 funding round.
Mytide Therapeutics's investors include Errik Anderson, Uncommon Denominator.
Mytide Therapeutics has raised $7.0M across 1 funding round. Most recently, it raised $7.0M Series A in March 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 8, 2022 | $7.0M Series A | Errik Anderson | Uncommon Denominator |